These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20570876)

  • 21. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis.
    Blake GJ; Ridker PM
    Eur Heart J; 2001 Mar; 22(5):349-52. PubMed ID: 11207073
    [No Abstract]   [Full Text] [Related]  

  • 22. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases].
    Wilhelmsen L; Wedel H; Conroy R; Fitzgerald T
    Lakartidningen; 2004 May; 101(20):1798-801. PubMed ID: 15198087
    [No Abstract]   [Full Text] [Related]  

  • 24. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients?
    Moyad MA
    Urol Clin North Am; 2004 May; 31(2):195-8. PubMed ID: 15123398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin overprescription in primary cardiovascular prevention.
    Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
    Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?].
    Nanchen D; Chiolero A; Marques-Vidal PM; Cornuz J; Waeber G; Vollenweider P; Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):488-90, 492-3. PubMed ID: 20373694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 28. Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.
    Masi S; Charakida M; Wang G; O'Neill F; Taddei S; Deanfield J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S61-4. PubMed ID: 19675441
    [No Abstract]   [Full Text] [Related]  

  • 29. Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk.
    Campbell NR; Khan NA; Grover SA
    J Hypertens; 2006 Sep; 24(9):1683-5. PubMed ID: 16915012
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid abnormalities and cardiovascular risk in the elderly.
    Milionis HJ; Elisaf MS; Mikhailidis DP
    Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diet and cardiovascular disease prevention the need for a paradigm shift.
    Hu FB
    J Am Coll Cardiol; 2007 Jul; 50(1):22-4. PubMed ID: 17601540
    [No Abstract]   [Full Text] [Related]  

  • 32. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk.
    Girndt M; Kohler H
    Nephrol Dial Transplant; 2003 Oct; 18(10):1976-9. PubMed ID: 13679468
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular risk of the general population assessed through SCORE and CUORE charts: an extensive survey by the General Practitioners from Abruzzo, Italy.
    Manzoli L; Palumbo W; Ruotolo P; Panella M; Mezzetti A; Di Stanislao F
    Int J Cardiol; 2010 Sep; 144(1):47-52. PubMed ID: 19406491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taking risks: primary prevention of cardiovascular events.
    Vallance P
    N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
    [No Abstract]   [Full Text] [Related]  

  • 35. Fish oil and omega-3 fatty acids.
    Jenkins DJ; Josse AR
    CMAJ; 2008 Jan; 178(2):150. PubMed ID: 18195286
    [No Abstract]   [Full Text] [Related]  

  • 36. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 37. [Disordered lipid metabolism--current diagnostics].
    Schwandt P
    MMW Fortschr Med; 2003 Mar; 145(13):26-7. PubMed ID: 15101528
    [No Abstract]   [Full Text] [Related]  

  • 38. The type 2 tablet. Evidence based medication for type 2 diabetes.
    Phillips P; Braddon J
    Aust Fam Physician; 2003 Jun; 32(6):431-6. PubMed ID: 12833770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
    Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
    Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.